Discovery of novel VEGFR2 inhibitors against non-small cell lung cancer based on fingerprint-enhanced graph attention convolutional network

Abstract Despite the proven inhibitory effects of drugs targeting vascular endothelial growth factor receptor 2 (VEGFR2) on solid tumors, including non-small cell lung cancer (NSCLC), the development of anti-NSCLC drugs solely targeting VEGFR2 still faces risks such as off-target effects and limited...

Full description

Saved in:
Bibliographic Details
Main Authors: Zixiao Wang, Lili Sun, Yu Xu, Jing Huang, Fang Yang, Yu Chang
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-024-05893-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items